5-(propan-2-yl)-2,3-dihydro-1H-pyrazol-3-one, 97%, 250mg

4-Hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylic acid, 97.0%, 1g

R-(+)-LANSOPRAZOLE, 97.0%, 250mg

5-Borono-2-chloro-4-fluorobenzoic acid, 98+%, 5g

4-Fluorobenzofuran, 95.0%, 100mg

N,N-Diphenyl-4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-4-amine, 98%, 100mg

Colonna HPLC NUCLEODUR® NH2-RP 5 µm, 250 mm, 4.6 mm, 1 Pezzo(i)

2,4-Difluorobenzoylacetonitrile, 95.0%, 1g

(R)-2-hydroxypropyl 4-methylbenzenesulfonate, 10g

Sodium bisulfate pearls, 92.0%, 5kg

4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]morpholine>98.0%(GC)(T)5g

3-Chloro-4'-(methylthio)benzophenone, 97.0%, 1g

N-Boc-N'-Mesyl ethylenediamine, 98%, 1g